全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量
2034

相关文章

更多...

Poor Dissociation of Patient-Evaluated Apathy and Depressive Symptoms

DOI: 10.1155/2012/846075

Full-Text   Cite this paper   Add to My Lib

Abstract:

Apathy has traditionally been conceptualised as part of depression. The appropriateness of this conceptualisation has now been questioned, with the realization that apathy constitutes a distinct neuropsychiatric condition, with separate rehabilitation and patient-care implications to depression. Research on the relationship between apathy and depression has, however, produced mixed results. One reason for this inconsistency may lie behind who does the apathy evaluation. In this study we investigated whether the relationship between apathy and depression would differ when apathy was evaluated by the patients or an informant. A total of 49 brain damaged patients were assessed on self- and informant-rated Apathy Evaluation Scales. The relationship between the apathy scores and depressive symptoms was then investigated. Patient-rated, and not informant-rated apathy significantly correlated with depression. We discuss the implication of these results on the relationship between the two neuropsychiatric conditions and also in relation to the utility of patient self-evaluations in apathy. 1. Introduction The position of apathy as a distinct syndrome in both clinical practice and research is still uncertain and less clearly defined. Generally, apathy is conceptualised as constituting a significant loss of motivation [1]. For diagnostic purposes, this loss of motivation must be present for at least four weeks and should manifest in at least two of three dimensions of apathy involving reduced overt acts, cognitive activity, and affective responses related to goal directed behaviour [2]. The clinical importance of apathy is demonstrated through its association with reduced patient independence, social integration, rehabilitation success, and increased caregiver burden [3] and its high prevalence in patients suffering neurological change [4]. For instance, incidence of between 17–70% has been reported in Parkinson’s disease [5, 6], and incidence of between 46 and 71% has been reported in patients with traumatic brain injury [7, 8]. Similar high incidence rates have been reported in Alzheimer’s disease, frontotemporal dementia, progressive supranuclear palsy, and stroke [9–11]. See also [12] for a review. Much of the debate on apathy in the past decade has focused on its nosological position, particularly its relation to depressive symptoms [6, 13–16]. Traditionally, apathy has been viewed as a symptom of depression. Clinically, the two disorders are related in that they significantly overlap on symptom dimensions related to loss of interest, anhedonia, and reduced

References

[1]  R. S. Marin, “Apathy—who cares? An introduction to apathy and related disorders of diminished motivation,” Psychiatric Annals, vol. 27, no. 1, pp. 18–23, 1997.
[2]  P. Robert, C. U. Onyike, A. F. G. Leentjens et al., “Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders,” European Psychiatry, vol. 24, no. 2, pp. 98–104, 2009.
[3]  J. M. Gray, M. Shephard, W. W. McKinlay, I. Robertson, and B. Pentland, “Negative symptoms in the traumatically brain-injured during the first year postdischarge, and their effect on rehabilitation status, work status and family burden,” Clinical Rehabilitation, vol. 8, no. 3, pp. 188–197, 1994.
[4]  R. S. Marin, “Differential diagnosis and classification of apathy,” American Journal of Psychiatry, vol. 147, no. 1, pp. 22–30, 1990.
[5]  A. F. G. Leentjens, K. Dujardin, L. Marsh et al., “Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations,” Movement Disorders, vol. 23, no. 14, pp. 2004–2014, 2008.
[6]  S. Varanese, B. Perfetti, M. F. Ghilardi, and A. Di Rocco, “Apathy, but not depression, reflects inefficient cognitive strategies in Parkinson's disease,” PLoS ONE, vol. 6, no. 3, Article ID e17846, 2011.
[7]  S. Andersson, J. M. Krogstad, and A. Finset, “Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reactivity,” Psychological Medicine, vol. 29, no. 2, pp. 447–456, 1999.
[8]  R. Kant, J. D. Duffy, and A. Pivovarnik, “Prevalence of apathy following head injury,” Brain Injury, vol. 12, no. 1, pp. 87–92, 1998.
[9]  S. E. Starkstein, L. Ingram, M. L. Garau, and R. Mizrahi, “On the overlap between apathy and depression in dementia,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 8, pp. 1070–1074, 2005.
[10]  R. S. Marin, R. C. Biedrzycki, and S. Firinciogullari, “Reliability and validity of the apathy evaluation scale,” Psychiatry Research, vol. 38, no. 2, pp. 143–162, 1991.
[11]  K. Onoda, Y. Kuroda, Y. Yamamoto et al., “Post-stroke apathy and hypoperfusion in basal ganglia: SPECT study,” Cerebrovascular Diseases, vol. 31, no. 1, pp. 6–11, 2010.
[12]  R. van Reekum, D. T. Stuss, and L. Ostrander, “Apathy: why care?” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 17, no. 1, pp. 7–19, 2005.
[13]  S. Hama, H. Yamashita, S. Yamawaki, and K. Kurisu, “Post-stroke depression and apathy: interactions between functional recovery, lesion location, and emotional response,” Psychogeriatrics, vol. 11, no. 1, pp. 68–76, 2011.
[14]  R. G. Brown and G. Pluck, “Negative symptoms: the 'pathology' of motivation and goal-directed behaviour,” Trends in Neurosciences, vol. 23, no. 9, pp. 412–417, 2000.
[15]  R. Kant, J. D. Duffy, and A. Pivovarnik, “Prevalence of apathy following head injury,” Brain Injury, vol. 12, no. 1, pp. 87–92, 1998.
[16]  S. D. Sperry, M. E. Strauss, and A. M. Landes, “The relation of apathy and depression, cognition and daily function in dementia (abstract),” Journal of the International Neuropsychological Society, vol. 7, p. 190, 2001.
[17]  A. M. Landes, S. D. Sperry, and M. E. Strauss, “Prevalence of apathy, dysphoria, and depression in relation to dementia severity in Alzheimer's disease,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 17, no. 3, pp. 342–349, 2005.
[18]  S. E. Starkstein, M. Merello, R. Jorge et al., “A validation study of depressive syndromes in Parkinson's disease,” Movement Disorders, vol. 23, no. 4, pp. 538–546, 2008.
[19]  D. G. Andrewes, Neuropsychology; From Theory to Practice, Psychology Press, Taylor & Francis Group, New York, NY, USA, 2004.
[20]  R. S. Marin, “Apathy and related disorders of diminished motivation,” in American Psychiatry Association Review of Psychiatry, L. J. Dickstein, M. B. Riba, and J. M. Oldham, Eds., pp. 205–242, American Psychiatric Press, Washington, DC, USA, 1996.
[21]  D. Feil, J. Razani, K. Boone, and I. Lesser, “Apathy and cognitive performance in older adults with depression,” International Journal of Geriatric Psychiatry, vol. 18, no. 6, pp. 479–485, 2003.
[22]  G. Kuzis, L. Sabe, C. Tiberti, F. Dorrego, and S. E. Starkstein, “Neuropsychological correlates of apathy and depression in patients with dementia,” Neurology, vol. 52, no. 7, pp. 1403–1407, 1999.
[23]  M. L. Levy, J. L. Cummings, L. A. Fairbanks et al., “Apathy is not depression,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 10, no. 3, pp. 314–319, 1998.
[24]  S. E. Starkstein, J. P. Fedoroff, T. R. Price, R. Leiguarda, and R. G. Robinson, “Apathy following cerebrovascular lesions,” Stroke, vol. 24, no. 11, pp. 1625–1630, 1993.
[25]  F. Skidmore, M. Yang, L. Baxter, et al., “Reliability analysis of the resting state can sensitively and specifically identify the presence of Parkinson disease,” Neuroimage. In press.
[26]  V. A. Holthoff, B. Beuthien-Baumann, E. Kalbe et al., “Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression,” Biological Psychiatry, vol. 57, no. 4, pp. 412–421, 2005.
[27]  M. Oguru, H. Tachibana, K. Toda, B. Okuda, and N. Oka, “Apathy and depression in parkinson disease,” Journal of Geriatric Psychiatry and Neurology, vol. 23, no. 1, pp. 35–41, 2010.
[28]  R. S. Marin, S. Firinciogullari, and R. C. Biedrzycki, “The sources of convergence between measures of apathy and depression,” Journal of Affective Disorders, vol. 28, no. 2, pp. 117–124, 1993.
[29]  M. L. Levy, J. L. Cummings, L. A. Fairbanks et al., “Apathy is not depression,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 10, no. 3, pp. 314–319, 1998.
[30]  T. Lindén, C. Blomstrand, and I. Skoog, “Depressive disorders after 20 months in elderly stroke patients: a case-control study,” Stroke, vol. 38, no. 6, pp. 1860–1863, 2007.
[31]  M. L. Hackett, C. Yapa, V. Parag, and C. S. Anderson, “Frequency of depression after stroke: a systematic review of observational studies,” Stroke, vol. 36, no. 6, pp. 1330–1340, 2005.
[32]  G. C. Pluck and R. G. Brown, “Apathy in Parkinson's disease,” Journal of Neurology Neurosurgery and Psychiatry, vol. 73, no. 6, pp. 636–642, 2002.
[33]  D. E. Clarke, R. van Reekum, M. Simard, D. L. Streiner, M. Freedman, and D. Conn, “Apathy in dementia: an examination of the psychometric properties of the apathy evaluation scale,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 19, no. 1, pp. 57–64, 2007.
[34]  R. L. Drijgers, K. Dujardin, J. S. A. M. Reijnders, L. Defebvre, and A. F. G. Leentjens, “Validation of diagnostic criteria for apathy in Parkinson's disease,” Parkinsonism and Related Disorders, vol. 16, no. 10, pp. 656–660, 2010.
[35]  M. Hamilton, “A rating scale for depression,” Journal of neurology, neurosurgery, and psychiatry, vol. 23, pp. 56–62, 1960.
[36]  M. B. Glenn, D. T. Burke, T. O'Neil-Pirozzi, R. Goldstein, L. Jacob, and J. Kettell, “Cutoff score on the apathy evaluation scale in subjects with traumatic brain injury,” Brain Injury, vol. 16, no. 6, pp. 509–516, 2002.
[37]  S. E. Starkstein, S. Brockman, D. Bruce, and G. Petracca, “Anosognosia is a significant predictor of apathy in Alzheimer's disease,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 22, no. 4, pp. 378–383, 2010.
[38]  J. L. Cummings, M. Mega, K. Gray, S. Rosenberg-Thompson, D. A. Carusi, and J. Gornbein, “The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia,” Neurology, vol. 44, no. 12, pp. 2308–2314, 1994.
[39]  D. E. Clarke, J. Y. Ko, E. A. Kuhl, R. van Reekum, R. Salvador, and R. S. Marin, “Are the available apathy measures reliable and valid? A review of the psychometric evidence,” Journal of Psychosomatic Research, vol. 70, no. 1, pp. 73–97, 2011.
[40]  R. P. Snaith and A. S. Zigmond, HADS, The NFER-Nelson, Berkshire, UK, 1994.
[41]  A. T. Beck, Beck Depression Inventory, The Psychological Corporation, San Antonio, Tex, USA, 1978.
[42]  S. E. Starkstein, H. S. Mayberg, T. J. Preziosi, P. Andrezejewski, R. Leiguarda, and R. G. Robinson, “Reliability, validity, and clinical correlates of apathy in Parkinson's disease,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 4, no. 2, pp. 134–139, 1992.
[43]  K. Dujardin, P. Sockeel, M. Delliaux, A. Destée, and L. Defebvre, “The Lille Apathy Rating Scale: validation of a caregiver-based version,” Movement Disorders, vol. 23, no. 6, pp. 845–849, 2008.
[44]  P. H. Robert, S. Claire, M. Benoit et al., “The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment,” International Journal of Geriatric Psychiatry, vol. 17, no. 12, pp. 1099–1105, 2002.
[45]  R. David, E. Mulin, L. Friedman, F. L. Duff, E. Cygankiewicz, and O. Deschaux, “Activity associated with apathy in Alzheimer disease: an actigraphic study,” American Journal of Geriatric Psychiatry. In press.
[46]  O. Spreen and E. Strauss, A Compendium of Neuropsychological Tests, Oxford University Press, New York, NY, USA, 1998.
[47]  M. D. Lezak, D. B. Howieson, and D. W. Loring, Neuropsychological Assessment, Oxford University Pres, New York, NY, USA, 2004.
[48]  D. T. Wade, “Measurement in neurological rehabilitation,” Current Opinion in Neurology and Neurosurgery, vol. 5, no. 5, pp. 682–686, 1992.
[49]  T. N. Chase, “Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment,” Neurotoxicity Research, vol. 19, no. 2, pp. 266–278, 2011.
[50]  G. B. Frisoni, L. Rozzini, A. Gozzetti et al., “Behavioral syndromes in Alzheimer's disease: description and correlates,” Dementia and Geriatric Cognitive Disorders, vol. 10, no. 2, pp. 130–138, 1999.
[51]  P. Aalten, M. E. de Vugt, R. Lousberg et al., “Behavioral problems indementia: a factor analysis of the neuropsychiatric inventory,” Dementia and Geriatric Cognitive Disorders, vol. 15, no. 2, pp. 99–105, 2003.
[52]  D. T. Stuss, R. Van Reekum, and K. J. Murphy, “Differentiation of states and causes of apathy,” in The Neuropsychology of Emotion, J. Borod, Ed., pp. 340–363, Oxford University Press, New York, NY, USA, 2000.
[53]  I. H. Richard, “Apathy does not equal depression in Parkinson's disease: why we should care,” Neurology, vol. 67, no. 1, pp. 10–11, 2006.
[54]  D. T. Stuss and D. F. Benson, The Frontal Lobes, Raven Press, New York, NY, USA, 1986.
[55]  J. Grafman and I. Litvan, “Importance of deficits in executive functions,” The Lancet, vol. 354, no. 9194, pp. 1921–1923, 1999.
[56]  J. M. Fleming, J. Strong, and R. Ashton, “Self-awareness of deficits in adults with traumatic brain injury: how best to measure?” Brain Injury, vol. 10, no. 1, pp. 1–15, 1996.
[57]  B. K. Schefft, J. F. Malec, B. K. Lehr, and F. H. Kanfer, “The role of self-regulation therapy with the brain-injured client,” in Clinical Neuropsychology: Theoretical Foundations for Practitioners, M. E. Maurish and J. A. Moses, Eds., pp. 237–282, Erlbaum, Mahwah, NJ, USA, 1997.
[58]  R. Migliorelli, A. Teson, L. Sabe et al., “Anosognosia in Alzheimer's disease: a study of associated factors,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 7, no. 3, pp. 338–344, 1995.
[59]  L. G. Apostolova, G. G. Akopyan, N. Partiali et al., “Structural correlates of apathy in Alzheimer's disease,” Dementia and Geriatric Cognitive Disorders, vol. 24, no. 2, pp. 91–97, 2007.
[60]  S. E. Starkstein, R. Mizrahi, A. A. Capizzano, L. Acion, S. Brockman, and B. D. Power, “Neuroimaging correlates of apathy and depression in Alzheimer's disease,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 21, no. 3, pp. 259–265, 2009.
[61]  J. L. Robinson, C. E. Bearden, E. S. Monkul et al., “Fronto-temporal dysregulation in remitted bipolar patients: an fMRI delayed-non-match-to-sample (DNMS) study,” Bipolar Disorders, vol. 11, no. 4, pp. 351–360, 2009.
[62]  R. C. van der Mast, D. J. Vinkers, M. L. Stek et al., “Vascular disease and apathy in old age. The Leiden 85-plus study,” International Journal of Geriatric Psychiatry, vol. 23, no. 3, pp. 266–271, 2008.
[63]  I. Galynker, C. Ieronimo, C. Miner, J. Rosenblum, N. Vilkas, and R. Rosenthal, “Methylphenidate treatment of negative symptoms in patients with dementia,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 9, no. 2, pp. 231–239, 1997.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133